United States Pharmacovigilence Retapamulin-Prescribing

Clinical trial NCT01153880 · COMPLETED

Trial details

NCT number: NCT01153880
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Skin Infections, Bacterial

Start date: 2008-12-01
Primary completion: 2012-08-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.